Patents Represented by Attorney Scott Loftus-Reid
  • Patent number: 8293753
    Abstract: The present invention relates to compounds of formula I and salts thereof, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameliorated by inhibition of phosphatidylinositol 3-kinase.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: October 23, 2012
    Assignee: Novartis AG
    Inventors: Robin Alec Fairhurst, Pascal Furet, Marc Gerspacher, Robert Mah